Literature DB >> 12361185

Homocysteine and ADMA--emerging risk factors for cardiovascular disease?

Thomas Hedner, Anders Himmelmann, Lennart Hansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12361185     DOI： 10.1080/08037050213763

Source DB:  PubMed          Journal:  Blood Press        ISSN： 0803-7051            Impact factor:   2.835


× No keyword cloud information.
  3 in total

1.  Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1.

Authors:  Ruslan Rafikov; Olga Rafikova; Saurabh Aggarwal; Christine Gross; Xutong Sun; Julin Desai; David Fulton; Stephen M Black
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

2.  Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.

Authors:  Zoltan Nemeth; Attila Cziraki; Sandor Szabados; Bernadett Biri; Sandor Keki; Akos Koller
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

3.  Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis.

Authors:  Dejan Spasovski; Arif Latifi; Bashkim Osmani; Svetlana Krstevska-Balkanov; Irena Kafedizska; Maja Slaninka-Micevska; Beti Dejanova; Sonja Alabakovska; Trajan Balkanov
Journal:  Arthritis       Date:  2013-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.